PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of eidLink to Publisher's site
 
Emerg Infect Dis. 1998 Apr-Jun; 4(2): 229–237.
PMCID: PMC2640137

Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease.

Abstract

We analyzed national Haemophilus influenzae (Hi) surveillance data from 1994 and 1995 to describe the epidemiology of Hi invasive disease among persons of all ages. Serotype data were available for 376 (56%) of 669 reported Hi cases among children aged 4 years or younger; 184 (49%) were H. influenzae type b (Hib). Among children aged 4 or younger, incidence (per 100,000) of all Hi invasive disease was 1.8 in 1994 and 1.6 (p < 0.05) in 1995. Children aged 5 months or younger had the highest average annual incidence rate of Hib invasive disease (2.2 per 100,000); children aged 6 to 11 months had the next highest rate (1.2 per 100,000)(p < 0.05). Of 181 children with Hib invasive disease whose age in months was known, 85 (47%) were too young (aged 5 months or younger) to have completed a primary series with an Hib-containing vaccine. Of the 83 children with known vaccination status who were eligible to receive a primary series (aged 6 months or older), 52 (63%) were undervaccinated, and the remaining 31 (37%) had completed a primary series in which vaccine failed. Among persons aged 5 years or older with Hi invasive disease, the lowest average annual incidence was among those 20 to 39 years of age (0.15 per 100,000), and the highest was among those aged 80 years or older (2.26 per 100,000). Among persons aged 5 years or older, serotype data were available for 1,372 (71%) of the 1,940 Hi invasive disease cases; 159 (28%) of the 568 Hi cases with known serotype were due to Hib.

Full Text

The Full Text of this article is available as a PDF (136K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Cochi SL, Broome CV, Hightower AW. Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. JAMA. 1985 Jan 25;253(4):521–529. [PubMed]
  • Strebel PM, Sutter RW, Cochi SL, Biellik RJ, Brink EW, Kew OM, Pallansch MA, Orenstein WA, Hinman AR. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis. 1992 Feb;14(2):568–579. [PubMed]
  • Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1995. MMWR Morb Mortal Wkly Rep. 1996 Oct 25;45(42):901–906. [PubMed]
  • Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, Wenger JD. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993 Jan 13;269(2):221–226. [PubMed]
  • Reported vaccine-preventable diseases--United States, 1993, and the childhood immunization initiative. MMWR Morb Mortal Wkly Rep. 1994 Feb 4;43(4):57–60. [PubMed]
  • Farley MM, Stephens DS, Brachman PS, Jr, Harvey RC, Smith JD, Wenger JD. Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC Meningitis Surveillance Group. Ann Intern Med. 1992 May 15;116(10):806–812. [PubMed]
  • Takala AK, Eskola J, van Alphen L. Spectrum of invasive Haemophilus influenzae type b disease in adults. Arch Intern Med. 1990 Dec;150(12):2573–2576. [PubMed]
  • Steinhart R, Reingold AL, Taylor F, Anderson G, Wenger JD. Invasive Haemophilus influenzae infections in men with HIV infection. JAMA. 1992 Dec 16;268(23):3350–3352. [PubMed]
  • Kostman JR, Sherry BL, Fligner CL, Egaas S, Sheeran P, Baken L, Bauwens JE, Clausen C, Sherer DM, Plorde JJ, et al. Invasive Haemophilus influenzae infections in older children and adults in Seattle. Clin Infect Dis. 1993 Sep;17(3):389–396. [PubMed]
  • National, state, and urban area vaccination coverage levels among children aged 19-35 months--United States, January-December 1995. MMWR Morb Mortal Wkly Rep. 1997 Feb 28;46(8):176–182. [PubMed]
  • Murphy TV, Osterholm MT, Pierson LM, White KE, Breedlove JA, Seibert GB, Kuritsky JN, Granoff DM. Prospective surveillance of Haemophilus influenzae type b disease in Dallas County, Texas, and in Minnesota. Pediatrics. 1987 Feb;79(2):173–180. [PubMed]
  • Ward JI, Lum MK, Hall DB, Silimperi DR, Bender TR. Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial. J Infect Dis. 1986 Jan;153(1):17–26. [PubMed]
  • Cochi SL, Fleming DW, Hightower AW, Limpakarnjanarat K, Facklam RR, Smith JD, Sikes RK, Broome CV. Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. J Pediatr. 1986 Jun;108(6):887–896. [PubMed]
  • Granoff DM, Basden M. Haemophilus influenzae infections in Fresno County, California: a prospective study of the effects of age, race, and contact with a case on incidence of disease. J Infect Dis. 1980 Jan;141(1):40–46. [PubMed]
  • Standaert SM, Lefkowitz LB, Jr, Horan JM, Hutcheson RH, Schaffner W. The reporting of communicable diseases: a controlled study of Neisseria meningitidis and Haemophilus influenzae infections. Clin Infect Dis. 1995 Jan;20(1):30–36. [PubMed]
  • Mohle-Boetani JC, Ajello G, Breneman E, Deaver KA, Harvey C, Plikaytis BD, Farley MM, Stephens DS, Wenger JD. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J. 1993 Jul;12(7):589–593. [PubMed]
  • Barbour ML. Conjugate vaccines and the carriage of Haemophilus influenzae type b. Emerg Infect Dis. 1996 Jul-Sep;2(3):176–182. [PMC free article] [PubMed]
  • Recommendations of the Advisory Committee on Immunization Practices: programmatic strategies to increase vaccination coverage by age 2 years--linkage of vaccination and WIC services. MMWR Morb Mortal Wkly Rep. 1996 Mar 15;45(10):217–218. [PubMed]
  • Campbell JR, Szilagyi PG, Rodewald LE, Doane C, Roghmann KJ. Patient-specific reminder letters and pediatric well-child-care show rates. Clin Pediatr (Phila) 1994 May;33(5):268–272. [PubMed]
  • Abramson JS, O'Shea TM, Ratledge DL, Lawless MR, Givner LB. Development of a vaccine tracking system to improve the rate of age-appropriate primary immunization in children of lower socioeconomic status. J Pediatr. 1995 Apr;126(4):583–586. [PubMed]
  • Dini EF, Linkins RW, Chaney M. Effectiveness of computer-generated telephone messages in increasing clinic visits. Arch Pediatr Adolesc Med. 1995 Aug;149(8):902–905. [PubMed]
  • Recommendations of the Advisory Committee on Immunization Practices: programmatic strategies to increase vaccination rates--assessment and feedback of provider-based vaccination coverage information. MMWR Morb Mortal Wkly Rep. 1996 Mar 15;45(10):219–220. [PubMed]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention